has slowed overall earnings momentum in 2014/2015, we estimate that by 2015 more than two-thirds of earnings will be in higher growth businesses of Optum, Medicaid, and Med Adv. What coupled with best-in-class business momentum, diversification, and assets, we expect the stock to migrate toward an S&

e reform implementation given the multiple moving parts such as exchanges, guaranteed issue, employer dumping, etc. Additionally, the potential for Optum earnings ramp may be slower than expected. Were the earnings ramp here to be more modest than expected (or extend beyond the 2015 target), then tha

f Technology and Product Officer and Co-Founder, Health Fidelity, Inc. Prior to joining Health Fidelity, Mr. Shroff was VP of HIE and EHR Products at Optum (a division of UnitedHealthcare). He came to Optum by way of acquisition of Axolotl Corporation, a leader in the health information exchange (HIE) sp

alth Fidelity, Inc. Prior to joining Health Fidelity, Mr. Shroff was VP of HIE and EHR Products at Optum (a division of UnitedHealthcare). He came to Optum by way of acquisition of Axolotl Corporation, a leader in the health information exchange (HIE) space. Anand was also a founding member of the Oracle

will come in because they always want to co-invest with him) Can not do JV politically and don't need them technology wise: I. What they (HP, IBM, Optum) can offer is of limited value, vanilla applications for the US and other int. markets which are good and useful but not rocket science (cost contai

ome in because they always want to co-invest with him)<=div> Can not do JV politically and don't need them techn=logy wise: 1. What they (HP, IBM, Optum) can offe= is of limited value, vanilla applications for the US and other int. marke=s which are good and useful but not rocket science (cost contai

want to co-invest with him) Can not do JV politically and don't need them technology wise: EFTA_R1_01712206 EFTA02554639 1. What they (HP, IBM, Optum) can offer is of limited value, vanilla applications for the US and other int. markets which are good and useful but not rocket science (cost contai

will come in because they always want to co-invest with him) Can not do IV politically and don't need them technology wise: 1. What they (HP, IBM, Optum) can offer is of limited value, vanilla applications for the US and other int. markets which are good and useful but not rocket science (cost contai

ling and care-authorization portals across the country. The article added that the company said its investigation determined that Change Healthcare, Optum, UnitedHealthcare and UnitedHealth Group systems have been affected. Change also confirmed Thursday that ransomware group ALPHV, or Blackcat, made t